Formålet var at undersøge ekg - virkningen af intravenøst palonosetron ved enkeltdoser på 0, 25, 0, 75 eller 2, 25 mg i 221 raske forsøgsdeltagere.
The objective was to evaluate the ECG effects of IV administered palonosetron at single doses of 0.25, 0.75 or 2.25 mg in 221 healthy subjects.